Journey Medical Corp
DERM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001867066
No open-market purchases or sales by Journey Medical Corp insiders were filed in the last 90 days; 71 institutions reported holding it in 13F filings for Q2 2026, worth $75.2M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Journey Medical Corp changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 38 | 56 | +18 |
| Shares | 5.02M | 6.49M | +1.48M (+29.4%) |
| Value | $29.6M | $46.6M | +$17.0M (+57.5%) |
New holders (25)
Institutions that held Journey Medical Corp at the end of Q2 2025 but not at the end of Q1 2025.
Sold out (7)
Institutions that held Journey Medical Corp at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Cambridge Investment Research Advisors, Inc. | 338,050 | $1.99M |
| Citadel Advisors LLC | 49,259 | $290.6K |
| Millennium Management LLC | 21,473 | $126.7K |
| Jane Street Group, LLC | 18,599 | $109.7K |
| Acadian Asset Management LLC | 4,772 | $28.0K |
| Private Trust Co NA | 100 | $590 |
| FMR LLC | 2 | $13 |